A Unified Vision for Longevity
The 2026 Global Geroscience Summit concluded with a historic international agreement to treat 'biological aging' as a primary target for public health intervention.
Healthspan Over Lifespan
The focus has officially shifted from simply extending life to extending 'healthspan'—the period of life spent in good health.
Official Insight
The ARDD 2026 meeting in Copenhagen further solidified the molecular targets for the next decade of research.
Strategic Data Expansion 2026.4
The summit highlighted that a slower rate of aging leads to a delay in the appearance of multiple chronic diseases simultaneously.
[Photo of global scientists and policymakers at the 2026 Geroscience Summit]
By the end of 2026, the goal is to have standardized 'Longevity Biomarkers' used globally to track the efficacy of anti-aging therapies.